The latest company to join CBE’s industry consortium, Genentech has been leading biotechnology innovation for more than 40 years. Genentech discovers, develops, manufactures and commercializes medicines to treat patients with serious or life-threatening medical conditions. Headquartered in South San Francisco, the company also has additional facilities in California, Oregon and Kentucky, with more than 14,000 employees.
Kyle Konis received a Ph.D in Architecture with UC Berkeley’s Building Science Program in 2011. He is now an Assistant Professor of Architecture at USC, and recently completed a book, co-authored with Stephen Selkowitz, Effective Daylighting With High-Performance Facades, Emerging Design Practices. In our interview he discusses how he is working to bridge the gap between building science research and design practice.